Cargando…

Augmentation of Anti‐tumor Immunity in Low‐responder Mice by Various Biological Response Modifiers: Analysis of Effector Mechanism

In order to elucidate the role of biological response modifiers (BRMs) in anti‐tumor immunotherapy, we examined their effect on the induction of anti‐tumor immunity in low‐responder mice which hardly exhibit anti‐tumor resistance against syngeneic Rous sarcoma virus (RSV)‐induced tumors, such as BIO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toko, Toshiyuki, Fujimoto, Shigeyoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1989
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5917921/ https://www.ncbi.nlm.nih.gov/pubmed/2560774 http://dx.doi.org/10.1111/j.1349-7006.1989.tb01657.x

Ejemplares similares

Systems-Biology Approaches to Discover Anti-Viral Effectors of the Human Innate Immune Response
por: Münk, Carsten, et al.
Publicado: (2011)

Tyrosine kinase inhibitor imatinib augments tumor immunity by depleting effector regulatory T cells
por: Tanaka, Atsushi, et al.
Publicado: (2019)

Sequential T Cell Response Involved in Tumor Rejection of Sarcoma, Meth A, in Syngeneic Mice
por: Jiao, Yan, et al.
Publicado: (1998)

How the immune system responds to therapeutic biological agents
por: Vultaggio, Alessandra, et al.
Publicado: (2016)

Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
por: Héninger, Erika, et al.
Publicado: (2015)

Antibody responsiveness during immunization and challenge of genetically modified antibody responder mice with murine hepatitis virus 3
por: Vassão, Ruth C., et al.
Publicado: (2003)

Augmentation of Human Cytotoxic T Lymphocytes against Autologous Tumor by a Factor Released from Human Monocytic Leukemia Cell Line
por: Maeda, Nagamasa, et al.
Publicado: (1989)

GENETIC CONTROL OF THE IMMUNE RESPONSE : FREQUENCY AND CHARACTERISTICS OF ANTIGEN-BINDING CELLS IN HIGH AND LOW RESPONDER MICE
por: Hämmerling, Günter J., et al.
Publicado: (1973)

CD47(Low) Status on CD4 Effectors Is Necessary for the Contraction/Resolution of the Immune Response in Humans and Mice
por: Van, Vu Quang, et al.
Publicado: (2012)

Effector triggered immunity: Activation of innate immunity in metazoans by bacterial effectors
por: Rajamuthiah, Rajmohan, et al.
Publicado: (2014)

Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis
por: Kurata, Izumi, et al.
Publicado: (2019)

Biologic terrorism--responding to the threat.
por: Russell, P K
Publicado: (1997)

Remodeling of the tumor microenvironment via disrupting Blimp1(+) effector Treg activity augments response to anti-PD-1 blockade
por: Dixon, Michael L., et al.
Publicado: (2021)

A method for selecting cis-acting regulatory sequences that respond to small molecule effectors
por: Allas, Ülar, et al.
Publicado: (2010)

CD4(+) cytotoxic T cells: an emerging effector arm of anti-tumor immunity
por: Jeong, Seongmin, et al.
Publicado: (2023)

Safety and anti-hyperglycemic efficacy of various tea types in mice
por: Han, Manman, et al.
Publicado: (2016)

Uncoupling of Proliferative Potential and Gain of Effector Function by CD8(+) T Cells Responding to Self-Antigens
por: Hernández, Javier, et al.
Publicado: (2002)

Comparison of Biological Responses in Rats Under Various Cigarette Smoke Exposure Conditions
por: Tsuji, Hiroyuki, et al.
Publicado: (2013)

Augmented Package of Palliative Care for Women With Cervical Cancer: Responding to Refractory Suffering
por: Krakauer, Eric L., et al.
Publicado: (2021)

COMPARATIVE ANALYSIS OF ANTIGEN-BINDING T CELLS IN GENETIC HIGH AND LOW RESPONDER MICE
por: Hämmerling, Günter J., et al.
Publicado: (1974)

Shp1 Loss Enhances Macrophage Effector Function and Promotes Anti-Tumor Immunity
por: Myers, Darienne R., et al.
Publicado: (2020)

Antigen-reactive T clones. III. Low responder antigen-presenting cells function effectively to present antigen to selected T cell clones derived from (High Responder x Low Responder)F1 mice
Publicado: (1981)

Enhancement of in vitro prostaglandin E2 production by mouse fibrosarcoma cells after co-culture with various anti-tumour effector cells.
por: Okada, F., et al.
Publicado: (1994)

Chimeric Antigen Receptor (CAR)-Modified Immune Effector Cell Therapy for Acute Myeloid Leukemia (AML)
por: Acharya, Utkarsh H., et al.
Publicado: (2020)

Low-affinity CD4+ T cells are major responders in the primary immune response
por: Martinez, Ryan J., et al.
Publicado: (2016)

Type VI Secretion Effectors: Methodologies and Biology
por: Lien, Yun-Wei, et al.
Publicado: (2017)

Effectors of Th1 and Th17 cells act on astrocytes and augment their neuroinflammatory properties
por: Prajeeth, Chittappen K., et al.
Publicado: (2017)

Binding of the transcription activator-like effector augments transcriptional regulation by another transcription factor
por: Leben, Katja, et al.
Publicado: (2022)

Corrigendum: Safety and anti-hyperglycemic efficacy of various tea types in mice
por: Han, Manman, et al.
Publicado: (2016)

Evaluation of anti-malaria potency of wild and genetically modified Enterobacter cloacae expressing effector proteins in Anopheles stephensi
por: Dehghan, Hossein, et al.
Publicado: (2022)

Biological Evaluation of Double Point Modified Analogues of 1,25-Dihydroxyvitamin D(2) as Potential Anti-Leukemic Agents
por: Corcoran, Aoife, et al.
Publicado: (2016)

Soil bacterial and fungal communities respond differently to various isothiocyanates added for biofumigation
por: Hu, Ping, et al.
Publicado: (2015)

Various biological functions of carbohydrate chains learned from glycosyltransferase-deficient mice
por: Asano, Masahide
Publicado: (2020)

Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal anti-tumor immunity
por: Choi, Yongbin, et al.
Publicado: (2023)

Engineering CatM, a LysR-Type Transcriptional Regulator, to Respond Synergistically to Two Effectors
por: Tumen-Velasquez, Melissa P., et al.
Publicado: (2019)

Augmenting chemotherapy with low-dose decitabine through an immune-independent mechanism
por: Gutierrez, Wade R., et al.
Publicado: (2022)

Chicken Anti-Campylobacter Vaccine – Comparison of Various Carriers and Routes of Immunization
por: Kobierecka, Patrycja A., et al.
Publicado: (2016)

Allotype-specific analysis of anti-(TYR,GLU)-ALA-LYS antibodies produced by Ir-1A high and low responder chimeric mice
por: Press, JL, et al.
Publicado: (1977)

Rainforest trees respond to drought by modifying their hydraulic architecture
por: Tng, David Y. P., et al.
Publicado: (2018)

Genetic control of the immune response to myoglobins. Both low and high responder T cells tolerant to the other major histocompatibility complex help high but not low responder B cells
por: Kohno, Y, et al.
Publicado: (1982)

Cannot write session to /tmp/vufind_sessions/sess_nj9a1tba04bgqdfgbf8u5a4nn9